Muscle injuries and repair: The role of prostaglandins and inflammation

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 1243-1256

  Prisk, V ^a   Huard, Johnny ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cyclooxygenase; Muscle injury; NSAIDs; Prostaglandins

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DECORIN; DICLOFENAC; FENBUFEN; FLURBIPROFEN; GAMMA INTERFERON; GROWTH FACTOR; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; MUSCLE PROTEIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SURAMIN; UNINDEXED DRUG; VALDECOXIB;

ADJUVANT THERAPY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUSION; CELL PROLIFERATION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; GASTROINTESTINAL DISEASE; HEALING; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; MYOFIBROSIS; MYOSITIS; NONHUMAN; ORTHOPEDIC SURGERY; PATHOGENESIS; PROTEIN SYNTHESIS; REVIEW; STEM CELL; TISSUE REPAIR; ULTRASOUND THERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; FIBROSIS; HUMANS; INFLAMMATION; MUSCLE PROTEINS; MUSCLE, SKELETAL; PROSTAGLANDINS; REGENERATION; WOUND HEALING;

EID: 0142031110     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Abramson S.B. and Weissmann G. (1989). The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 32, 1-9.
2. Almekinders L.C. (1999). Anti-inflammatory treatment of muscular injuries in sport. An update of recent studies. Sports Med. 28, 383-388.
3. Almekinders L.C. and Gilbert J.A. (1986). Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am. J. Sports Med. 14, 303-308.
4. Amemiya K., Semino-Mora C., Granger R.P. and Dalakas M.C. (2000). Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin. Immunol. 94, 99-104.
5. Barash I.A., Peters D., Friden J., Lutz G.J. and Lieber R.L. (2002). Desmin cytoskeletal modifications after a bout of eccentric exercise in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R958-R963.
6. Barnett J.G. and Ellis S. (1987). Prostaglandin E2 and the regulation of protein degradation in skeletal muscle. Muscle Nerve 10, 556-559.
7. Beaton L.J., Allan D.A., Tarnopolsky M.A., Tiidus P.M. and Phillips S.M. (2002). Contraction-induced muscle damage is unaffected by vitamin E supplementation. Med. Sci. Sports Exerc. 34, 798-805.
8. Beckman J.S. and Koppenol W.H. (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am. J. Physiol. 271, C1424-C1437.
9. Beiner J.M., Jokl P., Cholewicki J. and Panjabi M.M. (1999). The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury. Am. J. Sports Med. 27, 2-9.
10. Berlin T., Cronestrand R., Nowak J., Sonnenfeld T. and Wennmalm A. (1979). Conversion of arachidonic acid to prostaglandins in homogenates of human skeletal muscle and kidney. Acta Physiol. Scand. 106, 441-445.
11. Bernasconi P., Di Blasi C., Mora M., Morandi L., Galbiati S., Confalonieri P., Cornelio F. and Mantegazza R. (1999). Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul. Disord. 9, 28-33.
12. Bischoff R. (1994). The satellite cell and muscle regeneration. In: Myology. Basic and Clinical. 2nd ed. Engel A.G. and Franzini-Armstrong C. (eds). McGraw-Hill. New York. pp 97-118.
13. Botting R.M. (2000). Mechanism of action of acetaminophen: Is there a cyclooxygenase 3? Clin. Infect. Dis. 31, S202-S210.
14. Bourgeois J., MacDougall D., MacDonald J. and Tarnopolsky M. (1999). Naproxen does not alter indices of muscle damage in resistance-exercise trained men. Med. Sci. Sports Exerc. 31, 4-9.
15. Bradbury D.A., Newton R., Zhu Y.M., Stocks J., Corbett L., Holland E.D., Pang L.H. and Knox A.J. (2002). Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L717-L725.
16. Broekelmann T.J., Limper A.H., Colby T.V. and McDonald J.A. (1991). Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 88, 6642-6646.
17. Cao Y. and Prescott S.M. (2002). Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 190, 279-286.
18. Carpenter S. and Karpati G. (1989). Segmental necrosis and its demarcation in experimental micropuncture injury of skeletal muscle fibers. J. Neuropathol. Exp. Neurol. 48, 154-170.
19. Chan Y., Li Y., Horaguchi T. and Foster W. (2002). The antifibrotic effects of suramin in injured skeletal muscle 48th Annual Meeting of the Orthopaedic Research Society. Dallas, TX.
20. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S. and Simmons D.L. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc. Natl. Acad. Sci. USA 99, 13926-13931.
21. Childs A., Jacobs C., Kaminski T., Halliwell B. and Leeuwenburgh C. (2001). Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic. Biol. Med. 31, 745-753.
22. Clanton T.L., Zuo L. and Klawitter P. (1999). Oxidants and skeletal muscle function: Physiologic and pathophysiologic implications. Proc. Soc. Exp. Biol. Med. 222, 253-262.
23. Confalonieri P., Bernasconi P., Cornelio F. and Mantegazza R. (1997). Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J. Neuropathol. Exp. Neurol. 56, 479-484.
24. Croisier J.L., Forthomme B., Namurois M.H., Vanderthommen M. and Crielaard J.M. (2002). Hamstring muscle strain recurrence and strength performance disorders. Am. J. Sports Med. 30, 199-203.
25. Czaja M.J., Weiner F.R., Flanders K.C., Giambrone M.A., Wind R., Biempica L. and Zern M.A. (1989). In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J. Cell Biol. 108, 2477-2482.
26. Damon S.E., Haugk K.L., Birnbaum R.S. and Quinn L.S. (1998). Retrovirally mediated over-expression of insulin-like growth factor binding protein 4: Evidence that insulin-like growth factor is required for skeletal muscle differentiation. J. Cell. Physiol. 175, 109-120.
27. Day C.S., Buranapanitkit B., Riano F.A., Tomaino M.M., Somogyi G., Sotereanos D.G., Kuroda R. and Huard J. (2002). Insulin growth factor-1 decreases muscle atrophy following denervation. Microsurgery 22, 144-151.
28. De Asua L.J., O'Farrell M.K., Clingan D. and Rudland P.S. (1977). Temporal sequence of hormonal interactions during the prereplicative phase of quiescent cultured 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 74, 3845-3849.
29. Deasy B.M., Qu-Peterson Z., Greenberger J.S. and Huard J. (2002). Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 20, 50-60.
30. Diaz A., Varga J. and Jimenez S.A. (1989). Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J. Biol. Chem. 264, 11554-11557.
31. Doumit M.E., Cook D.R. and Merkel R.A. (1993). Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells. J. Cell. Physiol. 157, 326-332.
32. Ebisui C., Tsujinaka T., Morimoto T., Kan K., Iijima S., Yano M., Kominami E., Tanaka K. and Monden M. (1995). Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci. (Lond). 89, 431-439.
33. Elgendy H. and Hausman R.E. (1990). Prostaglandin-dependent phosphatidylinositol signaling during embryonic chick myogenesis. Cell Differ. Dev. 32, 109-115.
34. Elias J.A. (1988). Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am. Rev. Respir. Dis. 138, 652-658.
35. Engert J.C., Berglund E.B. and Rosenthal N. (1996). Proliferation precedes differentiation in IGF-1 stimulated myogenesis. J. Cell Biol. 135, 431-440.
36. Entwistle A., Zalin R.J., Bevan S. and Warner A.E. (1988a). The control of chick myoblast fusion by ion channels operated by prostaglandins and acetylcholine. J. Cell Biol. 106, 1693-1702.
37. Entwistle A., Zalin R.J., Warner A.E. and Bevan S. (1988b). A role for acetylcholine receptors in the fusion of chick myoblasts. J. Cell Biol. 106, 1703-1712.
38. Fielding R.A., Manfredi T.J., Ding W., Fiatarone M.A., Evans W.J. and Cannon J.G. (1993). Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 265, R166-R172.
39. Foster W., Li Y., Usas A., Somogyi G. and Huard J. (2003). Gamma interferon as an antifibrosis agent in skeletal muscle. J. Orthop. Res. (In press).
40. Frenette J., Cai B. and Tidball J. (2000). Complement activation promotes muscle inflammation during modified muscle use. Am. J. Pathol. 156, 2103-2110.
41. Frungieri M.B., Weidinger S., Meineke V., Kohn F.M. and Mayerhofer A. (2002). Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. USA 99, 15072-15077.
42. Fukushima K., Badlani N., Usas A., Riano F., Fu F. and Huard J. (2001). The use of an antifibrosis agent to improve muscle recovery after laceration. Am. J. Sports Med. 29. 394-402.
43. Garrett W.E. (1996). Muscle strain injuries. Am. J. Sports Med. 24, S2-S8.
44. Gilroy D.W., Saunders M.A. and Wu K.K. (2001). COX-2 expression and cell cycle progression in human fibroblasts. Am. J. Physiol. Cell Physiol. 281, C188-C194.
45. Goldstein R.H. and Polgar P. (1982). The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J. Biol. Chem. 257, 8630-8633.
46. Hausman R.E. and Berggrun D.A. (1987). Prostaglandin binding does not require direct cell-cell contact during chick myogenesis in vitro. Exp. Cell Res. 168, 457-462.
47. Hausman R.E., Dobi E.T., Woodford E.J., Petrides S., Ernst M. and Nichols E.B. (1986). Prostaglandin binding activity and myoblast fusion in aggregates of avian myoblasts. Dev. Biol. 113, 40-48.
48. Hausman R.E., Elgendy H. and Craft F. (1990). Requirement for G protein activity at a specific time during embryonic chick myogenesis. Cell Differ. Dev. 29, 13-20.
49. Hausman R.E. and Velleman S.G. (1981). Prostaglandin E1 receptors on chick embryo myoblasts. Biochem. Biophys. Res. Commun. 103, 213-218.
50. Haynes J.H., Johnson D.E., Mast B.A., Diegelmann R.F., Salzberg D.A., Cohen I.K. and Krummel T.M. (1994). Platelet-derived growth factor induces fetal wound fibrosis. J. Pediatr. Surg. 29, 1405-1408.
51. Hedenberg-Magnusson B., Ernberg M., Alstergren P. and Kopp S. (2002). Effect on prostaglandin E2 and leukotriene B4 levels by local administration of glucocorticoid in human masseter muscle myalgia. Acta Odontol. Scand. 60, 29-36.
52. Huard J., Li Y. and Fu F.H. (2002). Muscle injuries and repair: Current trends in research. J. Bone Joint Surg. Am. 84-A, 822-832.
53. Hughes C. 4th, Hasselman C.T., Best T.M., Martinez S. and Garrett W.E. (1995). Incomplete, intrasubstance strain injuries of the rectus femoris muscle. Am. J. Sports Med. 23, 500-506.
54. Hurme T., Kalimo H., Lehto M. and Jarvinen M. (1991). Healing of skeletal muscle injury: An ultrastructural and immunohistochemical study. Med. Sci. Sports Exerc. 23, 801-810.
55. Hurme T. and Kalimo H. (1992). Activation of myogenic precursor cells after muscle injury. Med. Sci. Sports Exerc. 24, 197-205.
56. Hussey H.J. and Tisdale M.J. (2000). Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model. Int. J. Cancer 87, 95-100.
57. Ina K., Kitamura H., Tatsukawa S., Takayama T., Fujikura Y. and Shimada T. (2002). Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy. Med. Electron Microsc. 35, 87-95.
58. Jackson M.J., Brooke M.H., Kaiser K. and Edwards R.H. (1991). Creatine kinase and prostaglandin E2 release from isolated Duchenne muscle. Neurology 41, 101-104.
59. Jourdan K.B., Evans T.W., Goldstraw P. and Mitchell J.A. (1999). Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: Concomitant and differential release. FASEB J. 13, 1025-1030.
60. Kaariainen M., Jarvinen T., Jarvinen M., Rantanen J. and Kalimo H. (2000). Relation between myofibers and connective tissue during muscle injury repair. Scand. J. Med. Sci. Sports 10, 332-337.
61. Kasemkijwattna C., Menetrey J., Bosch P., Moreland M.S., Fu F., Buranapanitkit B., Watkins S.C. and Huard J. (2000). The use of growth factors to improve muscle healing after strain injury. Clin. Orthop. 370, 272-285.
62. Kasemkijwattana C., Menetrey J., Somogyi G., Moreland M.S., Fu F., Buranapanitki B., Watkins S.C. and Huard J. (1998). Development of approaches to improve the healing following muscle contusion. Cell Transplant. 7, 585-598.
63. Keerthingam C.B., Jenkins R.G., Harrison N.K., Hernandez-Rodriguez N.A., Booth H., Laurent G.J., Hart S.L., Foster M.L. and McAnulty R.J. (2001). Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 158, 1411-1422.
64. Kellett J. (1986). Acute soft tissue injuries - A review of the literature. Med. Sci. Sports Exerc. 18, 489-500.
65. Khalil N., Whitman C., Zuo L., Danielpour D. and Greenberg A. (1993). Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 92, 1812-1818.
66. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W. and Herschman H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266, 12866-12872.
67. Langley B., Thomas M., Bishop A., Sharma M., Gilmour S. and Kambadur R. (2002). Myostatin inhibits myoblast differentiation by down regulating MyoD expression. J. Biol. Chem. 277, 49831-49840.
68. Lanning D.A., Diegelmann R.F., Yager D.R., Wallace M.L., Bagwell C.E. and Haynes J.H. (2000). Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds. J. Pediatr. Surg. 35, 183-187.
69. Lapointe B.M., Frenette J. and Cote C.H. (2002). Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion. J. Appl. Physiol. 92, 1995-2004.
70. Lewis A.J., Nelson D.J. and Sugrue M.F. (1974). Proceedings: Potentiation by prostaglandin E1 and arachidonic acid of oedema in the rat paw induced by various phlogogenic agents. Br. J. Pharmacol. 50, 468P-469P.
71. Lewis A.J., Nelson D.J. and Sugrue M.F. (1975). On the ability of prostaglandin E1, and arachidonic acid to modulate experimentally induced oedema in the rat paw. Br. J. Pharmacol. 55, 51-56.
72. Li Y. and Huard J. (2002). Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am. J. Pathol. 161, 895-907.
73. Lieber R.L., Shah S. and Friden J. (2002). Cytoskeletal disruption after eccentric contraction-induced muscle injury. Clin. Orthop. 403, S90-S99.
74. Liechty K.W., Adzick N.S. and Crombleholme T.M. (2000a). Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 12, 671-676.
75. Liechty K.W., Kim H.B., Adzick N.S. and Crombleholme T.M. (2000b). Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J. Pediatr. Surg. 35, 866-872.
76. Lijnen P.J., Petrov V.V. and Fagard R.H. (2000). Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol. Genet. Metab. 71, 418-435.
77. Logan A., Berry M., Gonzalez A.M., Frautschy S.A., Sporn M.B. and Baird A. (1994). Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6, 355-363.
78. MacIntyre D.L., Reid W.D., Lyster D.M. and McKenzie D.C. (2000). Different effects of strenuous eccentric exercise on the accumulation of neutrophils in muscle in women and men. Eur. J. Appl. Physiol. 81, 47-53.
79. MacIntyre D.L., Reid W.D., Lyster D.M., Szasz I.J. and McKenzie D.C. (1996). Presence of WBC, decreased strength, and delayed soreness in muscle after eccentric exercise. J. Appl. Physiol. 80, 1006-1013.
80. Mbebi C., Hantai D., Jandrot-Perrus M., Doyennette M.A. and Verdiere-Sahuque M. (1999). Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J. Cell. Physiol. 179, 305-314.
81. McAnulty R.J., Hernandez-Rodriguez N.A., Mutsaers S.E., Coker R.K. and Laurent G.J. (1997). Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem. J. 321, 639-643.
82. McArdle A., Edwards R.H. and Jackson M.J. (1991). Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. Clin. Sci. (Lond). 80, 367-371.
83. McArdle A., Edwards R.H. and Jackson M.J. (1992). Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro. Clin. Sci. (Lond). 82, 455-459.
84. McArdle A., Edwards R.H. and Jackson MJ. (1994). Release of creatine kinase and prostaglandin E2 from regenerating skeletal muscle fibers. J. Appl. Physiol. 76, 1274-1278.
85. McElligott M.A., Chaung L.Y., Baracos V. and Gulve E.A. (1988). Prostaglandin production in myotube cultures. Influence on protein turnover. Biochem. J. 253, 745-749.
86. McKinley C.J. and Turinsky J. (1986). Prostaglandin E2 and muscle proteolysis: Effect of burn injury and cycloheximide. Am. J. Physiol. 250, R207-R210.
87. McLennan I.S. (1985). Inhibition of prostaglandin synthesis produces a muscular dystrophy-like myopathy. Exp. Neurol. 89, 616-621.
88. McLennan I.S. (1987a). Characterization of a prostaglandin dysfunction myopathy. Muscle Nerve 10, 801-809.
89. McLennan I.S. (1987b). Hormonal regulation of myoblast proliferation and myotube production in vivo: Influence of prostaglandins. J. Exp. Zool. 241, 237-245.
90. McLennan I.S. (1991). E and F alpha series prostaglandins in developing muscles. Prostaglandins Leukot. Essent. Fatty Acids 43, 77-82.
91. McLennan I.S. (1993). Resident macrophages (ED2- and ED3-positive) do not phagocytose degenerating rat skeletal muscle fibres. Cell Tissue Res. 272, 193-196.
92. McMillan D.N., Reeds P.J., Lobley G.E. and Palmer R.M. (1987). Changes in protein turnover in hypertrophying plantaris muscles of rats: Effect of fenbufen - An inhibitor of prostaglandin synthesis. Prostaglandins 34, 841-852.
93. Mendler L., Zador E., Ver Heyen M., Dux L. and Wuytack F. (2000). Myostatin levels in regenerating rat muscles and in myogenic cell cultures. J. Muscle Res. Cell Motil. 21, 551-563.
94. Menetrey J., Kasemkijwattana C., Day C.S., Bosch P., Vogt M., Fu F.H., Moreland M.S. and Huard J. (2000). Growth factors improve muscle healing in vivo. J. Bone Joint Surg. Br. 82, 131-137.
95. Menetrey J., Kasemkijwattana C., Fu F.H., Moreland M.S. and Huard J. (1999). Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am. J. Sports Med. 27, 222-229.
96. Mense S. (1981). Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2. Brain Res. 225, 95-105.
97. Mishra D.K., Friden J., Schmitz M.C. and Lieber R.L. (1995). Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J. Bone Joint Surg. Am. 77, 1510-1519.
98. Murakami M., Nakatani Y., Kuwata H. and Kudo I. (2000a). Cellular components that functionally interact with signaling phospholipase A(2)s. Biochim. Biophys. Acta 1488, 159-166.
99. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., Ikeda T., Fueki M., Ueno A., Oh S. and Kudo I. (2000b). Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792.
100. Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., Ichikawa A., Aze Y., Tanaka T., Yoshida N., Ueno A., Oh-Ishi S. and Narumiya S. (1997). Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 388, 678-682.
101. O'Banion M.K., Winn V.D. and Young D.A. (1992). cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA 89, 4888-4892.
102. Obremsky W.T., Seaber A.V., Ribbeck B.M. and Garrett Jr. W.E. (1994). Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am. J. Sports Med. 22, 558-561.
103. O'Farrell M.K., Clingan D., Rudland P.S. and Jimenez De Asua L. (1979). Stimulation of the initiation of DNA synthesis and cell division in several cultured mouse cell types. Effect of growth-promoting hormones and nutrients. Exp. Cell. Res. 118, 311-321.
104. Orchard J. and Best T. (2002). The management of muscle strain injuries: An early return versus the risk of recurrence. Clin. J. Sport Med. 12, 3-5.
105. Orimo S., Hiyamuta E., Arahata K. and Sugita H. (1991). Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis. Muscle Nerve. 14, 515-520.
106. Palmer R.M., Campbell G.P., Whitelaw P.F., Brown D.S., Bain P.A. and Hesketh J.E. (1989). The cyclo-oxygenase inhibitors indomethacin and ibuprofen inhibit the insulin-induced stimulation of ribosomal RNA synthesis in L6 myoblasts. Biochem. J. 264, 101-106.
107. Palmer R.M., Reeds P.J., Atkinson T. and Smith R.H. (1983). The influence of changes in tension on protein synthesis and prostaglandin release in isolated rabbit muscles. Biochem. J. 214, 1011-1014.
108. Paoni N.F., Peale F., Wang F., Errett-Baroncini C., Steinmetz H., Toy K., Bai W., Williams M., Bunting S., Gerritsen M.E. and Powell-Braxton L. (2002). Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in the mouse. Physiol. Genomics 11, 263-272.
109. Pilbeam C.C., Kawaguchi H., Hakeda Y., Voznesensky O., Alander C.B. and Raisz L.G. (1993). Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268, 25643-25649.
110. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A. and Huard J. (2002). Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J. Cell. Biol. 157, 851-864.
111. Rantanen J., Ranne J., Hurme T. and Kalimo H. (1995a). Satellite cell proliferation and expression of myogenin and desmin in regenerating skeletal muscle: Evidence for two different populations of satellite cells. Lab. Invest. 72, 341-347.
112. Rantanen J., Ranne J., Hurme T. and Kalimo H. (1995b). Denervated segments of injured skeletal muscle fibers are reinnervated by newly formed neuromuscular junctions. J. Neuropathol. Exp. Neurol. 54, 188-194.
113. Rantanen J., Thorsson O., Wollmer P., Hurme T. and Kalimo H. (1999). Effects of therapeutic ultrasound on the regeneration of skeletal myofibers after experimental muscle injury. Am. J. Sports Med. 27, 54-59.
114. Reynolds J.F., Noakes T.D., Schwellnus M.P., Windt A. and Bowerbank P. (1995). Non-steroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. S. Afr. Med. J. 85, 517-522.
115. Rios R., Carneiro I., Arce V.M. and Devesa J. (2002). Myostatin is an inhibitor of myogenic differentiation. Am. J. Physiol. Cell Physiol. 282, C993-C999.
116. Rodemann H.P. and Goldberg A.L. (1982). Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J. Biol. Chem. 257, 1632-1638.
117. Rossi M.J., Clark M.A. and Steiner S.M. (1989). Possible role of prostaglandins in the regulation of mouse myoblasts. J. Cell. Physiol. 141, 142-147.
118. Salminen A. and Kihlstrom M. (1987). Protective effect of indomethacin against exercise-induced injuries in mouse skeletal muscle fibers. Int. J. Sports Med. 8, 46-49.
119. Saltzman L.E., Moss J., Berg R.A., Hom B. and Crystal R.G. (1982). Modulation of collagen production by fibroblasts. Effects of chronic exposure to agonists that increase intracellular cyclic AMP. Biochem. J. 204, 25-30.
120. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V. and Woolf C.J. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471-475.
121. Santini M.T., Indovina P.L. and Hausman R.E. (1987). Changes in myoblast membrane order during differentiation as measured by EPR. Biochim. Biophys. Acta 896, 19-25.
122. Santini M.T., Indovina P.L. and Hausman R.E. (1988). Prostaglandin dependence of membrane order changes during myogenesis in vitro. Biochim. Biophys. Acta 938, 489-492.
123. Sayers S.P., Knight C.A., Clarkson P.M., Van Wegen E.H. and Kamen G. (2001). Effect of ketoprofen on muscle function and sEMG activity after eccentric exercise. Med. Sci. Sports Exerc. 33, 702-710.
124. Scheuren N., Jacobs M., Ertl G. and Schorb W. (2002). Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction. J. Mol. Cell. Cardiol. 34, 29-37.
125. Schutzle U.B., Wakelam M.J. and Pette D. (1984). Prostaglandins and cyclic AMP stimulate creatine kinase synthesis but not fusion in cultured embryonic chick muscle cells. Biochim. Biophys. Acta. 805, 204-210.
126. Seeland U., Haeuseler C., Hinrichs R., Rosenkranz S., Pfitzner T., Scharffetter-Kochanek K. and Bohm M. (2002). Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur. J. Clin. Invest. 32, 295-303.
127. Sheehan S.M. and Allen R.E. (1999). Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J. Cell. Physiol. 181, 499-506.
128. Simon A.M., Manigrasso M.B. and O'Connor J.P. (2002). Cyclooxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17, 963-976.
129. Sinatra R. (2002). Role of COX-2 inhibitors in the evolution of acute pain management. J. Pain Symptom Manage. 24, S18-S27.
130. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K. and Isakson P.C. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA. 95, 13313-13318.
131. Smith R.H., Palmer R.M. and Reeds PJ. (1983). Protein synthesis in isolated rabbit forelimb muscles. The possible role of metabolites of arachidonic acid in the response to intermittent stretching. Biochem. J. 214, 153-161.
132. St Pierre B.A. and Tidball J.G. (1994). Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J. Appl. Physiol. 77, 290-297.
133. Steiner S.M., Hu Y. and Steiner MR. (1995). Regulation of prostaglandin H synthase 1 and 2 in MyoD transfected cells. Exp. Cell. Res. 218, 389-393.
134. Taylor L. and Polgar P. (1977). Self regulation of growth by human diploid fibroblasts via prostaglandin production. FEBS Lett. 79, 69-72.
135. Taylor W.E., Bhasin S., Artaza J., Byhower F., Azam M., Willard D.H. Jr, Kull F.C. Jr and Gonzalez-Cadavid N. (2001). Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280, E221-E228.
136. Tegeder I., Pfeilschifter J. and Geisslinger G. (2001). Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15, 2057-2072.
137. Thompson M.G., Acamovic F., Mackie S.C., Morrison K.S. and Palmer R.M. (1993). Arachidonate activation of protein kinase C may be involved in the stimulation of protein synthesis by insulin in L6 myoblasts. Biosci. Rep. 13, 359-366.
138. Thorsson O., Rantanen J., Hurme T. and Kalimo H. (1998). Effects of nonsteroidal antiinflammatory medication on satellite cell proliferation during muscle regeneration. Am. J. Sports Med. 26, 172-176.
139. Tidball J.G. (1995). Inflammatory cell response to acute muscle injury. Med. Sci. Sports Exerc. 27, 1022-1032.
140. Tilley S.L., Coffman T.M. and Koller B.H. (2001). Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15-23.
141. Trappe T.A., Fluckey J.D., White F., Lambert C.P. and Evans W.J. (2001). Skeletal muscle PGF(2)(alpha) and PGE(2) in response to eccentric resistance exercise: Influence of ibuprofen acetaminophen. J. Clin. Endocrinol. Metab. 86, 5067-5070.
142. Trappe T.A., White F., Lambert C.P., Cesar D., Hellerstein M. and Evans W.J. (2002). Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am. J. Physiol. Endocrinol. 282, E551-E556.
143. Turinsky J. and Loegering D.J. (1985). Prostaglandin E2 and muscle protein turnover in Pseudomonas aeruginosa sepsis. Biochim. Biophys. Acta. 840, 137-140.
144. Vandenburgh HH., Hatfaludy S., Sohar I. and Shansky J. (1990). Stretch-induced prostaglandins and protein turnover in cultured skeletal muscle. Am. J. Physiol. 259, C232-C240.
145. Vandenburgh H.H., Shansky J., Karlisch P. and Solerssi R.L. (1993). Mechanical stimulation of skeletal muscle generates lipid-related second messengers by phospholipase activation. J. Cell. Physiol. 155, 63-71.
146. Vandenburgh H.H., Shansky J., Solerssi R. and Chromiak J. (1995). Mechanical stimulation of skeletal muscle increases prostaglandin F2 alpha production, cyclooxygenase activity, and cell growth by a pertussis toxin sensitive mechanism. J. Cell. Physiol. 163, 285-294.
147. Vane J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231, 232-235.
148. Venkatesan N., Roughley P.J. and Ludwig M.S. (2002). Proteoglycan expression in bleomycin lung fibroblasts: Role of transforming growth factor-beta(1) and interferon-gamma. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L806-L814.
149. Verrall G.M., Slavotinek J.P., Barnes P.G., Fon G.T. and Spriggins A.J. (2001). Clinical risk factors for hamstring muscle strain injury: A prospective study with correlation of injury by magnetic resonance imaging. Br. J. Sports Med. 35, 435-439; discussion 440.
150. Walch L. and Morris P.L. (2002). Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors. Endocrinology 143, 3276-3283.
151. Warren G.L., Ingalls C.P., Lowe D.A. and Armstrong R.B. (2002). What mechanisms contribute to the strength loss that occurs during and in the recovery from skeletal muscle injury? J. Orthop. Sports Phys. Ther. 32, 58-64.
152. Wennmalm A. and Fitzgerald G.A. (1988). Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans. Am. J. Physiol. 255, H15-H18.
153. Wilgus T.A., Vodovotz Y., Vittadini E., Clubbs E.A. and Oberyszyn T.M. (2003). Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair Regen. 11, 25-34.
154. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P. and Halbwachs-Mecarelli L. (2000). Neutrophils: Molecules, functions and pathophysiological aspects. Lab. Invest. 80, 617-653.
155. Yamanouchi K., Soeta C., Naito K. and Tojo H. (2000). Expression of myostatin gene in regenerating skeletal muscle of the rat and its localization. Biochem. Biophys. Res. Commun. 270, 510-516.
156. Yamazaki M., Minota S., Sakurai H., Miyazono K., Yamada A., Kanazawa I. and Kawai M. (1994). Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am. J. Pathol. 144, 221-226.
157. Young E.W. and Sparks H.V. (1979). Prostaglandin E release from dog skeletal muscle during restricted flow exercise. Am. J. Physiol. 236, H596-H599.
158. Zalin R.J. (1977). Prostaglandins and myoblast fusion. Dev. Biol. 59, 241-248.
159. Zammit P. and Beauchamp J. (2001). The skeletal muscle satellite cell: Stem cell or son of stem cell? Differentiation 68, 193-204.
160. Zhang Y., Shaffer A., Portanova J., Seibert K. and Isakson P.C. (1997). Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J. Pharmacol. Exp. Ther. 283, 1069-1075.